NCT05358249 2026-04-14
KontRASt-03
Novartis
Phase 1/2 Active not recruiting
Clinical Trials
4 trialsNCT01872260 2026-04-01
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
Novartis
Phase 1/2 Active not recruiting
NCT05573555 2026-03-09
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)
Pfizer
Phase 1/2 Active not recruiting
NCT03090165 2026-01-02
Ribociclib and Bicalutamide in AR+ TNBC
Big Ten Cancer Research Consortium
Phase 1/2 Active not recruiting